ArticleJournal for immunotherapy of cancer2024

Tigilanol tiglate is an oncolytic small molecule that induces immunogenic cell death and enhances the response of both target and non-injected tumors to immune checkpoint blockade.

Jason K Cullen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.